US 9540641
Cancer treatment
granted A61KA61K31/7115A61K31/712
Quick answer
US patent 9540641 (Cancer treatment) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/7115, A61K31/712, A61K31/7125, A61P